Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Other Operating Expenses (2020 - 2025)

Biofrontera has reported Other Operating Expenses over the past 6 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $3.2 million for Q4 2025, up 135.9% from a year ago — trailing twelve months through Dec 2025 was $24.2 million (up 78.72% YoY), and the annual figure for FY2025 was $11.6 million, down 37.89%.
  • Other Operating Expenses for Q4 2025 was $3.2 million at Biofrontera, down from $6.9 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for BFRIW hit a ceiling of $13.4 million in Q3 2023 and a floor of -$9.0 million in Q4 2024.
  • Median Other Operating Expenses over the past 5 years was $4.0 million (2021), compared with a mean of $4.0 million.
  • Peak annual rise in Other Operating Expenses hit 6741.33% in 2023, while the deepest fall reached 168.13% in 2023.
  • Biofrontera's Other Operating Expenses stood at $1.8 million in 2021, then surged by 206.86% to $5.7 million in 2022, then plummeted by 168.13% to -$3.9 million in 2023, then tumbled by 132.78% to -$9.0 million in 2024, then surged by 135.9% to $3.2 million in 2025.
  • The last three reported values for Other Operating Expenses were $3.2 million (Q4 2025), $6.9 million (Q3 2025), and $6.8 million (Q2 2025) per Business Quant data.